Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1995 Dec;154(6):2103-9.
doi: 10.1016/s0022-5347(01)66706-5.

Radical retropubic prostatectomy: limited benefit of autologous blood donation

J R Goad  1 , J A Eastham, K B Fitzgerald, M W Kattan, M P Collini, D H Yawn, P T Scardino
Affiliations
Clinical Trial

Radical retropubic prostatectomy: limited benefit of autologous blood donation

J R Goad et al. J Urol. 1995 Dec.

Abstract

Purpose: We determine whether autologous blood donation significantly decreases the need for homologous transfusions after radical prostatectomy.

Materials and methods: The effects of estimated blood loss and autologous donation on the rate of homologous transfusions were analyzed in 3 groups of 100 consecutive patients treated between 1983 and 1992.

Results: Overall, donors were less likely than nondonors to receive homologous blood. As median estimated blood loss decreased from 1,200 to 800 cc from groups 1 to 3 (p < 0.05), the incidence of nondonors requiring homologous blood decreased from 62 to 11% and that of autologous units transfused decreased from 96 to 19%.

Conclusions: With decreasing blood loss, safe but stringent criteria for transfusion and improved safety of the blood supply, autologous donation is an inefficient method to lower the slight risk of complications following homologous transfusion during radical prostatectomy.

PubMed Disclaimer

Publication types